Transport protein variant and application thereof in preparation of R-pantoic acid

The transporter variant constructed by mutation of the panS gene has been improved, and the R-panol acid production of Saccharomyces cerevisiae is solved, and the R-panol acid production rate of Saccharomyces cerevisiae is low is achieved, thus achieving efficient and environmentally friendly industrialized biological production .

CN119082052AActive Publication Date: 2024-12-06ANHUI HUAHENG BIOTECH CO LTD +3
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411208633.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-01-18
Publication Date
2024-12-06
Estimated Expiration
2043-01-18

AI Technical Summary

Technical Problem

In the prior art, the yield of R-panol acid is low using Saccharomyces cerevisiae, which leads to accumulation in organisms and inhibits the activity of related syntheses, reduces the accumulation of R-panol acid in the extracellular cell, and traditional chemical synthesis methods There are high costs, environmental pollution and toxicity problems.

Method used

By performing site-directed mutation of the panS gene, the mutated transporter variant is constructed and introduced into the host strain to increase the R-panol acid production of yeast and achieve efficient fermentation production.

Benefits of technology

The fermentation yield of R-panolactin acid was significantly improved, and the R-panolactin acid yield of panS*S260A-S283G genetically engineered strain increased by 5.72 times, solving the problems of low yield and accumulation, and providing a green and environmentally friendly industrialized biological production pathway. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082052A_ABST
    Figure CN119082052A_ABST
Patent Text Reader

Abstract

The invention relates to a transporter panS variant and a coding gene thereof. Six transporter panS variants are constructed and transferred into saccharomyces cerevisiae to construct an R-pantoic acid production strain, and fermentation tests show that the yield of R-pantoic acid in fermentation liquor is remarkably increased. The variant has an application prospect in construction of an R-pantoic acid production strain.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of an application with a filing date of January 18, 2023, application number 202310062226.3, and invention name “A transport protein variant and its application in the preparation of R-pantoic acid”. Technical Field

[0002] The invention belongs to the field of biotechnology, and particularly relates to a transport protein and application thereof in the preparation of R-pantoic acid. Background Art

[0003] Pantothenic acid (VB5) is an important precursor for the biosynthesis of coenzyme A (CoA) and acyl carrier protein (ACP), and is a vitamin necessary for maintaining normal physiological functions of organisms. Pantothenic acid participates in the metabolism of carbohydrates, fatty acids, proteins and energy in organisms, and also participates in the synthesis of steroids, melatonin, antibodies and heme in the human body, and plays an important role in food, medicine, feed additives, etc.

[0004] Pantoic acid is an important intermediate in the production of pantothenic acid. D-pantothenic acid can be obtained by biosynthesizing R-pantothenic acid and then dehydrating and condensing it with β-alanine. Therefore, designing and reconstructing model strains such as Escherichia coli and Saccharomyces cerevisiae, and using non-natural life functional molecules / devices, including components, modules, circuits, chassis, etc., to construct engineered strains with high production of R-pantothenic acid will lay the foundation for the industrial biological production of D-pantothenic acid.

[0005] panS encodes a transporter that can transport pantothenate from the cell to the outside of the cell. Zhang Peng et al. studied the transcellular transport of substances driven by ABC transporters by the energy generated by the decomposition of ATP. Energy coupling factor (ECF) transporters are a new type of ABC transporter identified in recent years. They exist in microorganisms and plants and are responsible for the transmembrane transport of vitamins and trace nutrients (such as B vitamins, folic acid, pantothenic acid, riboflavin and metal ions). The ECF transporter structure consists of a substrate binding protein S on the cell membrane and an energy coupling module formed by transmembrane protein T and intracellular ATP binding protein A / A'. Substrate transport is achieved by the flipping of substrate binding protein S in the membrane, which has given people a new understanding of the transmembrane transport mechanism of substances that consume ATP (Xu et al, Nature. 497 (7448): 268-71. 2013). Furthermore, through structural comparison and functional analysis of pantothenate ECF transporter complexes from the same species, the molecular basis of the shared energy coupling module of ECF transporters was revealed (Zhang et al, PNAS. 111(52): 18560-5.2014)).

[0006] The traditional production method uses chemical methods for synthesis, and the cost of chiral resolving agents is high, separation is difficult, and there are environmental pollution and toxicity problems. With people's pursuit of green environmental protection, the production of R-pantoic acid products by microbial methods has attracted more and more attention. The microbial fermentation method has mild conditions, environmental friendliness, stable product quality, and has a promising future. As a eukaryotic model microorganism, Saccharomyces cerevisiae has the characteristics of clear genetic background, easy operation, tolerance to low pH, tolerance to high concentration substrates, simple nutritional requirements, low cost, and facultative anaerobicity. However, the yield of R-pantoic acid produced by Saccharomyces cerevisiae is currently low, which may be due to the accumulation of R-pantoic acid in the organism, which inhibits the activity of related synthases in its metabolic pathway, thereby reducing the accumulation of R-pantoic acid outside the cell. Therefore, it is a problem to be solved in the art to transform the original yeast strain using molecular biology technology to obtain a high-yield R-pantoic acid production strain derived from yeast. Summary of the invention

[0007] The present invention studies the structure of the panS gene, performs a series of site-directed mutations on panS, transfers the mutated panS gene into a host bacterium, and screens to obtain 6 panS variants that increase the yield of yeast R-pantoic acid. These panS variants can timely discharge the generated R-pantoic acid to the extracellular space to avoid accumulation in the cell, thereby increasing the fermentation yield of R-pantoic acid and improving the phenotypic activity of the panS gene.

[0008] The invention provides a mutated panS gene, an expression vector containing the mutated gene, an engineering bacterium containing the gene, and applications of the mutated panS gene in increasing the yield of R-pantoic acid and fermentation production.

[0009] The first aspect of the present invention relates to a nucleic acid molecule, comprising a nucleic acid molecule that substantially encodes a transporter protein that transfers R-pantoic acid from the inside of a cell to the outside of the cell, wherein the transporter protein has a mutation at the amino acid level relative to the wild type.

[0010] In one embodiment, the gene of the transporter with substantially increased enzyme activity is a mutated panS gene. The panS gene of the present invention is mutated compared to the wild-type panS gene (nucleotide sequence as shown in sequence 7 in the sequence list; amino acid sequence as shown in sequence 8 in the sequence list), and the mutated panS is transferred into the R-pantoic acid producing strain to increase the enzyme activity of the transporter panS, such as panS*T106I, panS*S283G, panS*S260A, panS*T106I-S283G, panS*T106I-S260A, panS*S260A-S283G, panS*T106I-S260A, panS*S260A-S283G, panS*T106I-S260A-S283G, as shown in sequences 9, 10, 11, 12, 13, 14, and 15 of the sequence list of the present application, respectively.

[0011] The present invention also relates to a genetically engineered strain comprising a mutated transporter protein panS gene.

[0012] In one embodiment, the gene that increases the enzymatic activity of the transporter panS may be a mutated panS gene.

[0013] As described above, the panS gene of the present invention can be inserted into a vector DNA and then introduced into the host. The panS gene of the present invention can be retained in the host as a plasmid-like extrachromosomal DNA, or the gene can be incorporated into the chromosome of the host microorganism by using transduction, translocon, Mu phage or homologous recombination. In order to effectively express the gene, the panS of the present invention can be placed under the control of a promoter such as lac, trp, PL and tac that functions in the microorganism.

[0014] In one embodiment, the R-pantoic acid fermentation engineered strain containing a mutated panS gene has an R-pantoic acid yield 5.72 times higher than that of an engineered strain containing a wild-type panS gene. The strain XAB-10 was submitted for patent deposit on December 5, 2022, with a deposit number of CCTCC NO: M 20221859, and is classified as Saccharomyces cerevisiae XAB-10. The depository unit is the China Center for Type Culture Collection, and the deposit address is Wuhan University, Wuhan, Hubei, China.

[0015] The genetically engineered strain of the present invention can be used for fermentation production of R-pantoic acid.

[0016] Compared with the prior art, the present invention has the following beneficial technical effects:

[0017] 1. The present invention provides a panS mutant and its encoding nucleic acid sequence

[0018] 2. The present invention provides a method for increasing the yield of R-pantoic acid, by expressing a mutated panS gene in a recombinant strain S.cerevisiaeBY 4741 (MATa, his3△1, leu2△0, met15△0, ura3△0) to increase the fermentation yield of R-pantoic acid, and using it for the construction of an R-pantoic acid engineering strain and the efficient fermentation of R-pantoic acid. The final R-pantoic acid yield of the genetically engineered strain of the present invention is 806μg / L, and the R-pantoic acid yield of the original strain is 120μg / L. The R-pantoic acid production capacity of the genetically engineered strain containing panS*S260A-S283G is increased by 5.72 times compared with the strain containing the wild-type panS gene, and has great industrial application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Molecular docking diagram of the SBF domain of panS and R-pantoic acid. DETAILED DESCRIPTION

[0020] The present invention is further illustrated by the following examples, but any example or combination thereof should not be construed as limiting the scope or implementation of the present invention. The scope of the present invention is defined by the appended claims. In combination with this specification and common knowledge in the art, a person of ordinary skill in the art can clearly understand the scope defined by the claims. Without departing from the spirit and scope of the present invention, a person of ordinary skill in the art can make any modification or change to the technical solution of the present invention, and such modification and change are also included in the scope of the present invention.

[0021] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods; the reagents and materials used, unless otherwise specified, can be obtained from commercial channels.

[0022] Table 1 Strains and plasmids used in the present invention

[0023]

[0024]

[0025] Table 2 Primers used in the present invention

[0026]

[0027]

[0028] Example 1: Construction of R-pantoic acid producing strain

[0029] (1) Overexpression of the ECM31 gene in Saccharomyces cerevisiae BY 4741

[0030] The CRISPR Cas9 method was used to overexpress the ECM31 gene (the nucleotide sequence is shown in Sequence 1 of the sequence table), and the specific steps were as follows:

[0031] In the first step, p426-SNR52p-gRNA plasmid DNA was used as a template and primers sg-ECM31-F / sg-ECM31-R (primers 13 and 14) were used to amplify the 6263bp DNA fragment I, which was transformed into TOP10 competent cells. A single clone was selected for sequencing. The sequencing primers were M13 Reverse / T7 (primers 19 and 20). After the sequencing was correct, the plasmid was extracted and named sg-ECM31 for future use.

[0032] In the second step, pSC-1 plasmid DNA was used as a template and primers GAL1-F / GAL1-R (primers 1 and 2) were used to amplify a 675 bp DNA fragment II for later use.

[0033] The amplification system was: Phusion 5X buffer (New England Biolabs) 10 μl, dNTP (dNTP concentration 10 mM) 1 μl, DNA template 20 ng, primers (10 μM) 2 μl each, Phusion High-Fidelity DNA polymerase (2.5 U / μl) 0.5 μl, distilled water 33.5 μl, and the total volume was 50 μl.

[0034] Amplification conditions were as follows: pre-denaturation at 98°C for 2 minutes (1 cycle); denaturation at 98°C for 10 seconds, annealing at 56°C for 10 seconds, and extension at 72°C for 1 minute (30 cycles); and extension at 72°C for 10 minutes.

[0035] The above DNA fragment II was used for gene editing: first, pUDP004 plasmid (purchased from ADDGENE, #101165) was transformed into Saccharomyces cerevisiae BY 4741 by electroporation, and then DNA fragment II was electroporated into Saccharomyces cerevisiae BY 4741 carrying pUDP004.

[0036] The electroporation conditions are as follows: First, prepare electroporation competent cells of Saccharomyces cerevisiae BY 4741 with pUDP004 plasmid. The preparation method is as follows: Cultivate fresh yeast liquid for competence: According to the 1% inoculation amount, connect 100μl seed liquid with 10ml culture medium to collect bacteria: Take 1.5ml culture and divide it into 1.5ml EP tubes. Centrifuge at 13000rpm for 1min, discard the supernatant, and suck it out with a gun. Wash the precipitate with 1ml sterile water, blow and centrifuge, discard the supernatant, and wash twice. Bacterial treatment: Add 1ml SOB liquid culture medium (4℃ refrigerator) + 10μl dithiothreitol solution, and heat at 25℃ for 20min. Centrifuge, discard the supernatant, suck it out with a gun, add 1ml pre-cooled 1M SOB liquid culture medium (4℃ refrigerator), blow, centrifuge, and discard the supernatant. Wash twice with 1M SOB liquid culture medium, aspirate and discard the supernatant, and then add 50μl SOB liquid culture medium to suspend. Add 3μl sg-ECM31 plasmid and 1.1μl DNA fragment II, mix well, transfer to pre-cooled electroporation cup, and place on ice for 5 minutes. Wipe the electroporation cup clean and electroshock at 2.7kv. Put the previously aspirated 1ml SOB liquid culture medium into the electroporation cup, mix well, and then aspirate into a new 1.5ml EP tube. Incubate at 30℃, 250rpm in a shaker for 40-60min. Centrifuge the bacterial solution, remove part of the supernatant, mix well, and apply to the corresponding plate, and incubate in a 30℃ incubator for 36h. Select a single colony for PCR verification, using primers yz-GAL1-F / yz-GAL1-R (primers 7 and 8). The correct colony amplification product is a fragment of 1142bp. Select a correct single colony and name it XAB-1.

[0037] (2) Overexpression of PAN5 gene in Saccharomyces cerevisiae XAB-1

[0038] The CRISPR Cas9 method was used to overexpress the PAN5 gene (the nucleotide sequence is shown in Sequence 2 of the sequence table), and the specific steps were as follows:

[0039] In the first step, using p426-SNR52p-gRNA plasmid DNA as a template, primers sg-pan5-F / sg-pan5-R (primers 15 and 16) were used to amplify the 6263bp DNA fragment I, which was transformed into TOP10 competent cells. A single clone was selected for sequencing. The sequencing primers were M13 Reverse / T7 (primers 19 and 20). After the sequencing was correct, the plasmid was extracted and named sg-pan5 for later use.

[0040] In the second step, pSC-1 plasmid DNA was used as a template and primers ENO2-F / ENO2-R (primers 3 and 4) were used to amplify a 727 bp DNA fragment II for later use.

[0041] The amplification system was: Phusion 5X buffer (New England Biolabs) 10 μl, dNTP (dNTP concentration 10 mM) 1 μl, DNA template 20 ng, primers (10 μM) 2 μl each, Phusion High-Fidelity DNA polymerase (2.5 U / μl) 0.5 μl, distilled water 33.5 μl, and the total volume was 50 μl.

[0042] Amplification conditions were as follows: pre-denaturation at 98°C for 2 minutes (1 cycle); denaturation at 98°C for 10 seconds, annealing at 56°C for 10 seconds, and extension at 72°C for 1 minute (30 cycles); and extension at 72°C for 10 minutes.

[0043] The above DNA fragment II was used for gene editing: DNA fragment II was electroporated into XAB-1 carrying pUDP004.

[0044] The electroporation conditions are as follows: First, prepare the electroporation competent cells of XAB-1 with pUDP004 plasmid. The preparation method is as follows: Cultivate fresh yeast liquid as competent cells. According to the inoculation amount of 1%, connect 100μl seed liquid with 10ml culture medium to collect bacteria: Take 1.5ml culture and divide it into 1.5ml EP tubes. Centrifuge at 13000rpm for 1min, discard the supernatant, and suck it out with a gun. Wash the precipitate with 1ml sterile water, blow and centrifuge, discard the supernatant, and wash twice. Bacteria treatment: add 1ml SOB liquid culture medium (4℃ refrigerator) + 10μl dithiothreitol solution, and heat at 25℃ for 20min. Centrifuge, discard the supernatant, suck it out with a gun, add 1ml pre-cooled 1M SOB liquid culture medium (4℃ refrigerator), blow, centrifuge, and discard the supernatant. Wash twice with 1M SOB liquid culture medium, aspirate and discard the supernatant, and then add 50μl SOB liquid culture medium to suspend. Add 3μl sg-pan5 plasmid and 1.1μl DNA fragment II, transfer to a pre-cooled electroporation cup and place on ice for 5 minutes. Wipe the electroporation cup clean and apply 2.7kv electric shock. Put the previously aspirated 1ml SOB liquid culture medium into the electroporation cup, mix well and aspirate into a new 1.5ml EP tube. Incubate at 30℃, 250rpm in a shaker for 40-60min. Centrifuge the bacterial solution, remove part of the supernatant, mix well and apply to the corresponding plate, and incubate in a 30℃ incubator for 36h. Select a single colony for PCR verification. The primers used are yz-ENO2-F / yz-ENO2-R (primers 9 and 10). The correct colony amplification product is a 1251bp fragment. Select a correct single colony and name it XAB-2.

[0045] (3) Overexpression of PAN6 gene in Saccharomyces cerevisiae XAB-2

[0046] The CRISPR Cas9 method was used to overexpress the PAN6 gene (the nucleotide sequence is shown in Sequence 3 of the sequence table), and the steps were as follows:

[0047] In the first step, using p426-SNR52p-gRNA plasmid DNA as a template, primers sg-pan6-F / sg-pan6-R (primers 17 and 18) were used to amplify the 6263bp DNA fragment I, which was transformed into TOP10 competent cells. A single clone was selected for sequencing. The sequencing primers were M13 Reverse / T7 (primers 19 and 20). After the sequencing was correct, the plasmid was extracted and named sg-pan6 for later use.

[0048] In the second step, pSC-1 plasmid DNA was used as a template and primers URA3-F / URA3-R (primers 5 and 6) were used to amplify a 263 bp DNA fragment II for later use.

[0049] The amplification system was: Phusion 5X buffer (New England Biolabs) 10 μl, dNTP (dNTP concentration 10 mM) 1 μl, DNA template 20 ng, primers (10 μM) 2 μl each, Phusion High-Fidelity DNA polymerase (2.5 U / μl) 0.5 μl, distilled water 33.5 μl, and the total volume was 50 μl.

[0050] Amplification conditions were as follows: pre-denaturation at 98°C for 2 minutes; denaturation at 98°C for 10 seconds, annealing at 56°C for 10 seconds, extension at 72°C for 1 minute (30 cycles); and extension at 72°C for 10 minutes.

[0051] The above DNA fragment II was used for gene editing: DNA fragment II was electroporated into XAB-2 carrying pUDP004.

[0052] The electroporation conditions are as follows: First, prepare the electroporation competent cells of XAB-2 with pUDP004 plasmid. The preparation method is as follows: Cultivate fresh yeast liquid as competent cells. According to the inoculation amount of 1%, connect 100μl seed liquid with 10ml culture medium to collect bacteria: Take 1.5ml culture and divide it into 1.5ml EP tubes. Centrifuge at 13000rpm for 1min, discard the supernatant, and suck it out with a gun. Wash the precipitate with 1ml sterile water, blow and centrifuge, discard the supernatant, and wash twice. Bacteria treatment: add 1ml SOB liquid culture medium (4℃ refrigerator) + 10μl dithiothreitol solution, and heat at 25℃ for 20min. Centrifuge, discard the supernatant, suck it out with a gun, add 1ml pre-cooled 1M SOB liquid culture medium (4℃ refrigerator), blow, centrifuge, and discard the supernatant. Wash twice with 1M SOB liquid culture medium, aspirate and discard the supernatant, and then add 50μl SOB liquid culture medium to suspend. Add 3μl sg-pan6 plasmid and 1.1μl DNA fragment II, transfer to a pre-cooled electroporation cup and place on ice for 5 minutes. Wipe the electroporation cup clean and apply 2.7kv electric shock. Put the previously aspirated 1ml SOB liquid culture medium into the electroporation cup, mix well and aspirate into a new 1.5ml EP tube. Incubate in a shaker at 30℃ and 250rpm for 40-60min. Centrifuge the bacterial solution, remove part of the supernatant, mix well and apply to the corresponding plate, and incubate in a 30℃ incubator for 36h. Select a single colony for PCR verification. The primers used are yz-URA3-F / yz-URA3-R (primers 11 and 12). The correct colony amplification product is a 768bp fragment. Select a correct single colony and name it XAB-3.

[0053] Example 2: Bioinformatics structure simulation of panS gene

[0054] The transporter protein encoded by the panS gene has three main domains, namely the N-terminal domain, the C-terminal domain and the catalytic domain SBF. Among them, R-pantoic acid was used as a substrate to perform molecular docking with the SBF domain of panS in AutoDock Vina to observe their interaction, such as Figure 1 As shown, R-pantoic acid forms hydrogen bonds with the G105, T106, A107, S108, S283, and S260 residues of panS, which are key residues of the active pocket. The inventors conducted a series of structural studies on the panS gene and found that mutations at the three sites of T106, S260, and S283 are closely related to the activity of the panS gene.

[0055] Using the panS gene as a template, homologous sequences were obtained by BLAST in NCBI, multiple sequence alignment was performed by Muscle in MEGA11, and Seqlogo was analyzed. The above residues were judged in Seqlogo whether they were non-completely conserved residues. If so, point mutations could be performed according to Seqlogo. Seven variants were obtained: panS*T106I, panS*S283G, panS*S260A, panS*T106I-S283G, panS*T106I-S260A, panS*S260A-S283G, and panS*T106I-S260A-S283G.

[0056] Example 3: Overexpression of panS mutant gene

[0057] A recombinant plasmid containing panS mutations was constructed, wherein the panS gene carried on the plasmid contained mutations of panS*T106I (amino acid sequence shown in Sequence 9 of the sequence listing), panS*S283G (amino acid sequence shown in Sequence 10 of the sequence listing), panS*S260A (amino acid sequence shown in Sequence 11 of the sequence listing), panS*T106I-S283G (amino acid sequence shown in Sequence 12 of the sequence listing), panS*T106I-S260A (amino acid sequence shown in Sequence 13 of the sequence listing), panS*S260A-S283G (amino acid sequence shown in Sequence 14 of the sequence listing), and panS*T106I-S260A-S283G (amino acid sequence shown in Sequence 15 of the sequence listing), and the above plasmids were introduced into Saccharomyces cerevisiae XAB-3 to overexpress the mutated panS gene. The specific steps are as follows:

[0058] The pYes2.0 plasmids carrying the above panS mutant gene and the wild-type panS gene (the nucleotide and amino acid sequences of the wild-type panS gene are shown in Sequence 7 and 8 in the sequence listing, respectively) were electroporated into XAB-3.

[0059] The electroporation conditions are as follows: First, prepare the electroporation competent cells of XAB-3. The preparation method is as follows: Cultivate fresh yeast liquid as competent cells. According to the inoculation amount of 1%, connect 100μl seed liquid with 10ml culture medium to collect bacteria: Take 1.5ml culture and divide it into 1.5ml EP tubes. Centrifuge at 13000rpm for 1min, discard the supernatant, and suck it out with a gun. Wash the precipitate with 1ml sterile water, blow and centrifuge, discard the supernatant, and wash twice. Bacteria treatment: Add 1ml SOB liquid culture medium (4℃ refrigerator) + 10μl dithiothreitol solution, and heat at 25℃ for 20min. Centrifuge, discard the supernatant, suck it out with a gun, add 1ml pre-cooled 1M SOB liquid culture medium (4℃ refrigerator), blow, centrifuge, and discard the supernatant. Wash twice with 1M SOB liquid culture medium, aspirate and discard the supernatant, and then add 50μl SOB liquid culture medium to suspend. Add 3μl of pYes2.0 plasmid and mix well, then transfer to a pre-cooled electroporation cup and place on ice for 5 minutes. Wipe the electroporation cup clean and apply 2.7kv electric shock. Place 1ml SOB liquid culture medium that has been sucked in the electroporation cup, mix well and then suck into a new 1.5ml EP tube. Incubate at 30℃, 250rpm in a shaker for 40-60min. Centrifuge the bacterial solution, remove part of the supernatant, mix well and apply to the corresponding plate, incubate in a 30℃ incubator for 36h, and pick out the transformants. The transformant strains and their corresponding panS genotypes are shown in the following table:

[0060] Table 3: Transformed strains containing the panS gene and their panS genotypes

[0061] strain panS gene mutation XAB-4 panS*T106I XAB-5 panS*S283G XAB-6 panS*S260A XAB-7 panS*T106I-S283G XAB-8 panS*T106I-S260A XAB-9 panS*T106I-S260A-S283G XAB-10 panS*S260A-S283G XAB-11 panS

[0062] Example 3: Fermentation production of R-pantoic acid using recombinant strains

[0063] Single clones of XAB-4, XAB-5, XAB-6, XAB-7, XAB-8, XAB-9, XAB-10, and XAB-11 were picked from the plate and inoculated into 5 mL of SD-Ura liquid medium (purchased from Beijing Fanjinuo Technology Co., Ltd., as fermentation medium) and cultured overnight at 30°C in a shaking incubator. 600 After growing to 2.0, 150 μl of seed solution was inoculated into a 100 mL Erlenmeyer flask containing 15 mL of SD-Ura liquid medium and cultured at 30°C and 250 rpm for 6 days. The fermentation broth of XAB-4, XAB-5, XAB-6, XAB-7, XAB-8, XAB-9, XAB-10, and XAB-11 was centrifuged at 12000 r / min for 5 min, and 1 mL of supernatant was diluted according to a certain ratio so that the content of R-pantoic acid was within the detection range of the instrument; after filtering through a sterile filter membrane, the concentration of R-pantoic acid was detected using HPLC.

[0064] HPLC detection conditions: the instrument is Primaide from Hitachi, Japan, the column model is EclipseXD8-C18 (5μm, 4.6mm×250mm), the column temperature is 30°C, the detector is an ultraviolet detector, the detection wavelength is 210nm, the mobile phase volume ratio is A (phosphoric acid): B (acetonitrile): C (water) = 1:50:950, the flow rate is 1mL / min, and the injection volume is 10μL. The detection results are shown in the following table.

[0065] Table 4: Comparison of production capacity of R-pantoic acid strains

[0066]

[0067]

[0068] As shown in Table 4, compared with the control group XAB-11, XAB-8, XAB-9, and XAB-10 have improved R-pantoic acid production rates, especially XAB-10 (panS*S260A-S283G) strain has a 5.72-fold increase in R-pantoic acid production capacity relative to XAB-11 (wild-type panS) strain. The experimental data showed that the R-pantoic acid production of XAB-10 reached 806 μg / L, and the panS activity was significantly improved, which could transport R-pantoic acid to the extracellular space, which was consistent with the results of molecular docking analysis.

[0069] The strain XAB-10 was submitted for patent deposit on December 5, 2022, with the deposit number CCTCC NO:M 20221859, and the classification name is Saccharomyces cerevisiae XAB-10. The depository unit is the China Center for Type Culture Collection, and the deposit address is Wuhan University, Wuhan, Hubei, China.

[0070] The above are only preferred embodiments of the present invention, and the protection scope of the present invention is not limited to the above embodiments. All technical solutions under the concept of the present invention belong to the protection scope of the present invention. It should be pointed out that for ordinary technicians in this technical field, some improvements and modifications without departing from the principle of the present invention should be regarded as the protection scope of the present invention.

Claims

1. A panS variant, characterized in that: Based on the amino acid sequence shown in Sequence 8 of the sequence listing, it contains the following mutations: T106I and / or S283G.

2. A nucleic acid molecule encoding the panS variant of claim 1.

3. A recombinant vector containing the nucleic acid according to claim 2.

4. Use of the panS variant according to claim 1, the nucleic acid according to claim 2, or the recombinant vector according to claim 3 in preparing an R-pantoic acid-producing strain.

5. A method for increasing the yield of R-pantoic acid, characterized in that: Expressing the gene encoding the panS variant of claim 1 in a host cell.

Citation Information

Patent Citations

  • Hansenula polymorpha mutant and application of expression vector of hansenula polymorpha mutant to recombinant protein expression

    CN104745492A

  • Construction method of high-yield pantothenic-acid genetically engineered bacterium and bacterium strain

    CN111100834A

  • High-yield D-pantothenic acid genetically engineered bacterium and construction and application thereof

    CN113462630A

  • Increased production of pantothenate (vitamin b5)

    WO2010018196A1